H Lawrence Culp Jr
CIK 1205247 · Chairman and CEO · last filed 2026-05-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
XRAY price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
1 NEUMANN WAY
CINCINNATI, OH 45215
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GEHC | Director | 344,553 | $71.11 | $24.50M | $5.05M | 9 | 2026-05-11 |
| GE | Chairman and CEO | 451,955 | $297.66 | $134.53M | $14.52M | 14 | 2026-03-04 |
| GE HealthCare Technologies Inc. (GEHCV) Delisted | Director | 581,483 | — | — | $0 | 1 | 2023-01-05 |
| TROW | Director | 9,826 | $103.63 | $1.02M | $0 | 5 | 2018-04-30 |
| XRAY | President and CEO | 1,251,768 | $9.35 | $11.70M | -$316.14M | 87 | 2014-07-22 |
Recent Filings · Page 5 of 12
116 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-01-02 | XRAY | Gift (G) | −89,735 | $0 | EDGAR |
| 2013-01-02 | XRAY | Grant (A) | — | $0 | EDGAR |
| 2012-10-29 | XRAY | Grant (A) | — | $0 | EDGAR |
| 2012-10-24 | XRAY | Mixed | −267,128 | -$44.62M | EDGAR |
| 2012-08-07 | XRAY | Sell (S) | −100,000 | -$5.35M | EDGAR |
| 2012-07-30 | XRAY | Grant (A) | — | $0 | EDGAR |
| 2012-05-08 | XRAY | Grant (A) | +154,835 | $0 | EDGAR |
| 2012-05-01 | XRAY | Grant (A) | — | $0 | EDGAR |
| 2012-05-01 | XRAY | Tax (F) | −11,816 | -$640.7K | EDGAR |
| 2012-04-24 | XRAY | Mixed | −123,600 | -$16.81M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.